Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy

In recent years, cancer immunotherapy has emerged as an exciting cancer treatment. Immune checkpoint blockade brings new opportunities for more researchers and clinicians. Programmed cell death receptor-1 (PD-1) is a widely studied immune checkpoint, and PD-1 blockade therapy has shown promising res...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Songlin, Wang, Haiyang, Shao, Xinzhe, Chen, Haonan, Chao, Shushu, Zhang, Yanyan, Gao, Zhaoju, Yao, Qingqiang, Zhang, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318732/
https://www.ncbi.nlm.nih.gov/pubmed/37403095
http://dx.doi.org/10.1186/s12951-023-01966-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318732/
https://www.ncbi.nlm.nih.gov/pubmed/37403095
http://dx.doi.org/10.1186/s12951-023-01966-4

Ejemplares similares